Not Yet RecruitingNot Applicable

Role of Arterial Spin Labelling Magnetic Resonance Prefusion in Grading of Pediatric Brain Tumors

20 participantsStarted 2026-03

Plain-language summary

To evaluate the diagnostic performance of arterial spin labelling (ASL) magnetic resonance perfusion in preoperative grading of pediatric brain tumors.

Who can participate

Age range0 Years – 18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Pediatric patients aged 18 years or younger.
✓. Patients with radiological diagnosis of intracranial brain tumors.

Exclusion criteria

✕. Patients who have received prior surgery, chemotherapy or radiotherapy for brain tumors.
✕. Patients with contraindications to magnetic resonance imaging (MRI) examination.

What they're measuring

Evaluate the diagnostic value of arterial spin labelling (ASL) magnetic resonance perfusion in pre-operative grading of pediatric brain tumors

Timeframe: preoperative

Trial details

NCT IDNCT07427316

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2028-03

Contact for this trial

Monica Boles

+20 01278489110 monica.sobhy94@gmail.com

View on ClinicalTrials.gov More Pediatric Brain Tumors trials